The global novel oral anticoagulants drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Anticoagulant drugs (also known as blood thinners) are chemical substances that prevent or reduce coagulation of blood and prolong the blood clotting time. These drugs are majorly used for high risk of blood clots in various medical conditions, such as atrial fibrillation, deep vein thrombosis, myocardial infarction, pulmonary embolism, stroke, and others. 

The major factors that are fuelling the growth of the global novel oral anticoagulants drugs market during the forecast period include increasing prevalence of venous thromboembolism (VTE) and cardiovascular disorders, rising awareness of NOACs in the developing region and growing adoption of novel oral anticoagulants (NOACs). Moreover, an increase in the number of obese and elderly people, higher unmet needs, and a surge in demand for novel therapeutics further support the market growth.

The global novel oral anticoagulants drugs market analysis includes some of the key market players such as Aspen Holdings, Bayer AG, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, and Daiichi Sankyo Company, among others.  

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered
• Regions Covered- Globally

Competitive Landscape: Aspen Holdings, Bayer AG, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, and Daiichi Sankyo Company, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Novel Oral Anticoagulants Drugs Market by Segment

By Type

• Direct Thrombin Inhibitor

• Factor Xa Inhibitors

By Application

• Hospital

• Drugs Stores

• Other

Global Novel Oral Anticoagulants Drugs Market by Region